Filing Details
- Accession Number:
- 0001719844-21-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-03 16:31:05
- Reporting Period:
- 2021-07-30
- Accepted Time:
- 2021-08-03 16:31:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1710155 | National Vision Holdings Inc. | EYE | Ophthalmic Goods (3851) | 464841717 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1719844 | R. Patrick Moore | C/O National Vision Holdings, Inc., 2435 Commerce Avenue, Bldg. 2200 Duluth GA 30096-4980 | Svp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-30 | 26,330 | $4.27 | 32,079 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-07-30 | 26,330 | $54.00 | 5,749 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-08-02 | 37,750 | $4.27 | 43,499 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-08-02 | 37,750 | $54.00 | 5,749 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-30 | 26,330 | $0.00 | 26,330 | $4.27 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-08-02 | 37,750 | $0.00 | 37,750 | $4.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,750 | 2024-09-16 | No | 4 | M | Direct | |
0 | 2024-09-16 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 21, 2021. These sales were the final transactions under this Rule 10b5-1 trading plan.
- The shares were sold pursuant to the Rule 10b5-1 plan in multiple transactions at the price of $54.
- These stock options are fully vested.